WAUWATOSA, WI - GE Healthcare proudly announced that it has been awarded two 10-year contracts (one year, with nine separate option years) by the Defense Supply Center Philadelphia (DSCP). Combined, these two contracts are valued at a maximum of $63,000,000 annually.
The contracts include products for comprehensive patient monitoring solutions, including acute patient monitoring, networking, telemetry systems, vital signs monitoring. DSCP customers can now select from GE Healthcare's integrated suite of patient monitoring devices, communications networks and IT systems designed to transform patient monitoring data into clinical intelligence enabling clinicians to make critical healthcare decisions faster and more efficiently.
In addition, these two contracts enable Federal agencies to select complementary GE Healthcare products including: diagnostic cardiology devices and MUSE® cardiology information archival systems; catheterization laboratory monitoring; Datex-Ohmeda anesthesia delivery, infant incubators and warmers; and fetal monitoring, perinatal information systems, and blood pressure cuffs.
Ad Statistics
Times Displayed: 128996
Times Visited: 7335 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The contracts can be utilized for purchasing GE medical equipment by the Army, Navy, Air Force, Marine Corps, Veterans Administration, and US Federal Government agencies worldwide. Each of these contracts has been under negotiations since April 2007, and are the first two Patient Monitoring vendor contracts to be awarded by the DSCP.
ABOUT GE HEALTHCARE:
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
